Study for the relationship between pediatric adenoid hypertrophy and mouth breathing

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900025983

Enrollment

Unknown

Registered

2019-09-16

Start date

2020-01-01

Completion date

Unknown

Last updated

2019-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenoid hypertrophy

Interventions

Medication group:Nasonex, once a night, bilateral nostrils, 3 sprays each side of the nostril, continuous use for a month

Surgery group:Adenoidectomy

Eligibility

Sex/Gender

All

Age

3 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1. The children who come to our department complaining with mouth opening breathing as the main symptom. 2. Children aged 3-12 years with adenoid congestion of posterior nostril more than 2/3 under nasal endoscopy. 3. Closed breathing test less than or equal to 3 minutes. 4. Aged 3-12 years.

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

Measure	Time frame
Time period for closed mouth breathing;	—

Secondary

Measure	Time frame
Disease course of open mouth breathing;Hypertrophy level of adenoid;Questionnaire scores of open mouth breathing ;	—

Countries

China

Contacts

Public ContactZhihua Zhang

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiaotong University School of Medicine

zhihua.zhang2015@aliyun.com+86 18019790369

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026